Skip to main content
NovaBay Pharmaceuticals, Inc. logo

NovaBay Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · NBY ISIN · US66987P2011 LEI · 549300D5U7PQPNEX8Q38 US Manufacturing
Filings indexed 1,026 across all filing types
Latest filing 2025-10-21 Regulatory Filings
Country US United States of America
Listing US NBY

About NovaBay Pharmaceuticals, Inc.

https://novabay.com/

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Recent filings

Filing Released Lang Actions
8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a Current Report used to announce major events that shareholders should know about. The text specifically states that the company, NovaBay Pharmaceuticals, has regained compliance with the NYSE American listing standards. It includes a press release as an exhibit announcing this compliance. The document does not contain detailed financial statements or comprehensive financial analysis, but rather an announcement of a significant event related to listing compliance. The length is 4351 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this filing is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories.
2025-10-21 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-21 English
Major Shareholding Notification 2025
Major Shareholding Notification
2025-10-21 English
FORM 4
Director's Dealing
2025-10-21 English
FORM 4
Director's Dealing
2025-10-21 English
FORM 4
Director's Dealing
2025-10-21 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.